CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 101 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2020. The put-call ratio across all filers is 0.24 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $16,783,000 | +420.6% | 496,548 | +260.3% | 0.01% | +400.0% |
| Q1 2021 | $3,224,000 | +1179.4% | 137,821 | +1473.3% | 0.00% | – |
| Q4 2020 | $252,000 | +125.0% | 8,760 | +58.1% | 0.00% | – |
| Q3 2020 | $112,000 | -83.6% | 5,540 | -75.7% | 0.00% | -100.0% |
| Q2 2020 | $684,000 | +233.7% | 22,760 | +249.1% | 0.00% | – |
| Q1 2020 | $205,000 | +40.4% | 6,519 | +110.4% | 0.00% | – |
| Q4 2019 | $146,000 | +2820.0% | 3,099 | +267.6% | 0.00% | – |
| Q3 2019 | $5,000 | -90.6% | 843 | -80.3% | 0.00% | – |
| Q2 2019 | $53,000 | -7.0% | 4,289 | +1.4% | 0.00% | – |
| Q1 2019 | $57,000 | +1325.0% | 4,230 | +297.9% | 0.00% | – |
| Q4 2018 | $4,000 | -50.0% | 1,063 | -5.8% | 0.00% | – |
| Q3 2018 | $8,000 | – | 1,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |